Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israele, Tel Aviv-Giaffa
Ari Raphael
29 anni di esperienza
accreditamenti :
Clinica certificata da :
| Israele | Turchia | Austria | |
| Bisturi Nanotecnologico | da $18,500 | da $9,500 | da $25,000 |
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Dr. Barak Rosenzweig, MD, directs the Urological Oncology Service at Sheba Medical Center. He is a uro-oncologic surgeon with nearly 20 years of experience. He treats complex urologic cancers with advanced robotic and minimally invasive methods. He is listed among Israel’s Best Doctors by Forbes.
Expertise includes tumors of the prostate, kidney, bladder, testis, and upper urinary tract. He performs robotic radical prostatectomy, kidney-sparing partial nephrectomy, and advanced laparoscopy. Diagnostics include MRI-guided fusion biopsy and imaging-based personalized planning.
He completed a Urological Oncology fellowship at Memorial Sloan Kettering Cancer Center. He is a Senior Physician in the Department of Urology and a Clinical Senior Lecturer at Tel Aviv University. He is a graduate of the Sheba Talpiot program. He is an active researcher with over 200 publications in urologic oncology.
Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.
MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.
Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.
Esperto di spicco nella tecnologia NanoKnife con un focus sulle malignità toraciche e sul profilo genomico innovativo presso il Sourasky Medical Center.
Top-rated NanoKnife specialists in Israel include Dr. Ilan Gielchinsky and Prof. Jack Baniel. These experts lead focal therapy at Hadassah and Sourasky Medical Centers. They specialize in irreversible electroporation for prostate and pancreatic cancers. Most hold certifications from the Israeli Board of Urology.
Bookimed Expert Insight: Data shows a strong trend of international training among Israel's top ablative surgeons. Dr. Almog Ben-Yaacov completed specialized NanoKnife training in London. Prof. Jack Baniel holds a consultation for $600 at Sourasky Medical Center. This global expertise helps them treat the most complex cases effectively.
Patient Consensus: Patients often mention how quickly they could walk after this minimally invasive procedure. They appreciate that the treatment avoids the side effects of traditional surgery. Many were surprised by the high level of personal care at Sourasky.
Hadassah Medical Center in Jerusalem was the first Israeli hospital to offer NanoKnife. They introduced this minimally invasive technology in 2018 for localized prostate cancer. The procedure uses electrical pulses to destroy cancer cells without harming critical surrounding tissues or nerves.
Bookimed Expert Insight: While Hadassah pioneered the technology, Sheba Medical Center has integrated NanoKnife into a multidisciplinary oncology framework. Dr. Almog Ben Yaacov at Sheba completed advanced NanoKnife training at King's College London. This international training helps specialists apply the technology to complex gastrointestinal and urological cases with high precision.
Patient Consensus: Patients note that the recovery is much faster compared to traditional thermal treatments. Many were relieved to find they could return to normal activities almost immediately. They often mention that the procedure felt less intensive and spared them from typical side effects.